Accepted for Publication: November 22, 2021.
Published: January 14, 2022. doi:10.1001/jamanetworkopen.2021.43781
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Choi KY et al. JAMA Network Open.
Corresponding Author: Henry Ho-lung Chan, PhD, Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong 00000 (henryhl.chan@polyu.edu.hk).
Author Contributions: Drs Chun and Chan had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Choi and Chun are co–first authors.
Concept and design: Choi, Chun, To, Lam, Chan.
Acquisition, analysis, or interpretation of data: Chun, Tang, Lam, Chan.
Drafting of the manuscript: Choi, Chun, Tang.
Critical revision of the manuscript for important intellectual content: Choi, Chun, To, Lam, Chan.
Statistical analysis: Choi, Chun, Tang, Lam.
Obtained funding: Chun, To, Chan.
Administrative, technical, or material support: Chun, Tang, To, Lam, Chan.
Supervision: Chan.
Conflict of Interest Disclosures: Dr Lam reported receiving a patent for DIMS lens with royalties paid from Hoya Corporation. No other disclosures were reported.
Funding/Support: This study was supported by the PolyU-HKIF Children Eye Care Project, the General Research Fund from the Research Grants Council (PolyU grant 151001/17M), the Health and Medical Research Fund from the Food and Health Bureau (grant 05161146), the Innovation and Technology Fund, and the Government of the Hong Kong Special Administrative Region.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Natalie Y. Y. Chan, BSc, Yvonne Y. T. Li, BSc, and Vivian W. Y. Lo, BSc (all from the School of Optometry, The Hong Kong Polytechnic University), assisted with data collection. They were not compensated for this work beyond their normal salaries.
5.Liu
J , Li
B , Sun
Y , Chen
Q , Dang
J . Adolescent vision health during the outbreak of COVID-19: association between digital screen use and myopia progression.
Front Pediatr. 2021;9:662984. doi:
10.3389/fped.2021.662984PubMedGoogle Scholar 11.Ip
JM , Rose
KA , Morgan
IG , Burlutsky
G , Mitchell
P . Myopia and the urban environment: findings in a sample of 12-year-old Australian school children.
Invest Ophthalmol Vis Sci. 2008;49(9):3858-3863. doi:
10.1167/iovs.07-1451PubMedGoogle ScholarCrossref 12.Choi
KY , Yu
WY , Lam
CHI ,
et al. Childhood exposure to constricted living space: a possible environmental threat for myopia development.
Ophthalmic Physiol Opt. 2017;37(5):568-575. doi:
10.1111/opo.12397PubMedGoogle ScholarCrossref 15.Zhang
X , Cheung
SSL , Chan
H-N ,
et al. Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study.
Br J Ophthalmol. Published online August 2, 2021. doi:
10.1136/bjophthalmol-2021-319307PubMedGoogle Scholar 22.Yam
JC , Jiang
Y , Tang
SM ,
et al. Low-concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control.
Ophthalmology. 2019;126(1):113-124. doi:
10.1016/j.ophtha.2018.05.029PubMedGoogle ScholarCrossref 26.Arumugam
B , Hung
LF , To
CH , Holden
B , Smith
EL
III . The effects of simultaneous dual focus lenses on refractive development in infant monkeys.
Invest Ophthalmol Vis Sci. 2014;55(11):7423-7432. doi:
10.1167/iovs.14-14250PubMedGoogle ScholarCrossref 31.Erdinest
N , London
N , Levinger
N , Lavy
I , Pras
E , Morad
Y . Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns.
Cont Lens Anterior Eye. 2021;101475. doi:
10.1016/j.clae.2021.101475PubMedGoogle Scholar